HGH Fragment 176-191 50 mg

HGHFragment 176-191 50 mg is presented here as a peptide reference identified by its stated fragment name and total listed quantity. The available product information describes this item as a 17-amino acid chain derived from the C-terminal end of the human growth hormone molecule. This page focuses on clear identification of the listing, the stated format and the key details that help distinguish it from other peptide references.

The supplied description indicates a 10-vial presentation, with each vial containing 5 mg in lyophilised form, giving a total listed quantity of 50 mg across the full kit. When checking similar listings, it is important to separate the total quantity for the full presentation from the amount stated for each individual vial. That distinction helps avoid confusion between a single-vial listing and a multi-vial kit.

Product identification and comparison

The main identifiers for this listing are the fragment name HGH Fragment 176-191, the total stated quantity of 50 mg and the model reference HGFG. If comparing different peptide listings, check the fragment numbering carefully, as small differences in naming can indicate a different peptide reference. Packaging format also matters: a 50 mg total presentation may be shown either as one container or as multiple vials, so the per-vial amount should always be read alongside the total listed quantity.

The existing product information also refers to a lyophilised presentation. Where this is shown on the packaging, it can help with cross-checking the listing against the printed label and manufacturer details. Retaining the original packaging is useful for product identification and any authenticity checks.

Technical information

Handling and packaging notes

Store according to the information printed on the original packaging. For verification purposes, check that the stated fragment name, total quantity, vial count and model reference are consistent across the outer packaging and any vial labels. If the packaging includes batch or manufacturer markings, these should also match the listed details where available.

Because peptide listings can appear in different strengths and pack formats, clear label reading is important for accurate identification. Keep the original packaging for reference, especially where multi-vial presentations are involved.

Frequently Asked Questions

Does 50 mg refer to each vial or the full kit?

Here, 50 mg refers to the full listed kit quantity. The supplied information states 10 vials, with 5 mg in each vial.

What does HGH Fragment 176-191 mean?

It identifies the stated peptide fragment by its numbered sequence reference. The numbering helps distinguish this listing from other peptide entries with different names or fragment ranges.

Is the product shown as a single container?

No. The available description indicates a multi-vial presentation rather than a single-container format.

What does lyophilised mean on this listing?

Lyophilised refers to a freeze-dried presentation, as stated in the supplied product information. This wording may also appear on the packaging for specification checks.

Why is the model reference useful?

The model HGFG provides an additional identifier that can help match the listing to packaging details and distinguish it from similarly named entries.

What should be checked on arrival for identification?

Check the fragment name, the 10-vial presentation, the 5 mg per-vial statement, the 50 mg total quantity and any matching model or batch information printed on the packaging.